Therefore, to mimic obesity condition in vitro, we first pre-treated BMDMs with GC-VLNs, followed by LPS priming and FFA treatment to activate the NLRP3 inflammasome. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.